ロード中...
Prevalence of mild cognitive impairment in type 2 diabetes mellitus is associated with serum galectin‐3 level
AIMS/INTRODUCTION: Galectin‐3 (Gal3) contributes to insulin resistance, inflammation and obesity, the three risk factors for mild cognitive impairment (MCI) in type 2 diabetes mellitus patients. MATERIALS AND METHODS: A total of 134 hospitalized type 2 diabetes mellitus patients were assessed by the...
保存先:
| 出版年: | J Diabetes Investig |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7477520/ https://ncbi.nlm.nih.gov/pubmed/32196999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13256 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|